The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

UK BROKER RATINGS SUMMARY: JPMorgan Upgrades Severn Trent To Neutral

Tue, 18th Feb 2020 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

JPMORGAN RAISES SEVERN TRENT TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 2550 (2000) PENCE

----------

KEPLER CHEUVREUX CUTS ASTRAZENECA PRICE TARGET TO 7700 (8000) PENCE - 'BUY'

----------

CITIGROUP CUTS BT GROUP PRICE TARGET TO 165 (205) PENCE - 'NEUTRAL'

----------

CITIGROUP CUTS COCA-COLA HBC TO 'NEUTRAL' ('BUY')

----------

MORGAN STANLEY CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 275 (300) PENCE - 'OVERWEIGHT'

----------

LIBERUM CUTS GLAXOSMITHKLINE PRICE TARGET TO 1840 (1930) PENCE - 'HOLD'

----------

JPMORGAN RAISES UNITED UTILITIES PRICE TARGET TO 1100 (900) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES COCA-COLA HBC PRICE TARGET TO 3100 (2900) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

UBS CUTS HASTINGS GROUP PRICE TARGET TO 182 (190) PENCE - 'NEUTRAL'

----------

BARCLAYS CUTS CONVATEC PRICE TARGET TO 182 (185) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM RAISES NETWORK INTERNATIONAL PRICE TARGET TO 680 (645) PENCE - 'BUY'

----------

JPMORGAN CUTS WEIR GROUP PRICE TARGET TO 1300 (1380) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES PENNON GROUP PRICE TARGET TO 1125 (760) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES PETRA DIAMONDS PRICE TARGET TO 11 (10) PENCE - 'HOLD'

----------

JEFFERIES RAISES DRAPER ESPRIT PRICE TARGET TO 727 (672) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.